Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 393 citing articles:

Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease
Kassandra Kisler, Amy R. Nelson, Axel Montagne, et al.
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 7, pp. 419-434
Open Access | Times Cited: 996
Alzheimer’s disease hypothesis and related therapies
Xiaoguang Du, Xinyi Wang, Meiyu Geng
Translational Neurodegeneration (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 534
Functional vascular contributions to cognitive impairment and dementia: mechanisms and consequences of cerebral autoregulatory dysfunction, endothelial impairment, and neurovascular uncoupling in aging
Péter Tóth, Stefano Tarantini, Anna Csiszár, et al.
AJP Heart and Circulatory Physiology (2016) Vol. 312, Iss. 1, pp. H1-H20
Open Access | Times Cited: 433
Glucose transporters in brain in health and disease
Hermann Koepsell
Pflügers Archiv - European Journal of Physiology (2020) Vol. 472, Iss. 9, pp. 1299-1343
Open Access | Times Cited: 375
Neuroinflammation in Alzheimer’s Disease
Isaac G. Onyango, Gretsen Velezmoro Jáuregui, Mária Čarná, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 524-524
Open Access | Times Cited: 203
Obstructive Sleep Apnea is Associated With Early but Possibly Modifiable Alzheimer’s Disease Biomarkers Changes
Claudio Liguori, Nicola Biagio Mercuri, Francesca Izzi, et al.
SLEEP (2017)
Open Access | Times Cited: 186
Immunometabolism in the Brain: How Metabolism Shapes Microglial Function
Louis‐Philippe Bernier, Elisa M. York, Brian A. MacVicar
Trends in Neurosciences (2020) Vol. 43, Iss. 11, pp. 854-869
Closed Access | Times Cited: 179
Dimethyl fumarate improves cognitive deficits in chronic cerebral hypoperfusion rats by alleviating inflammation, oxidative stress, and ferroptosis via NRF2/ARE/NF-κB signal pathway
Nao Yan, Zhipeng Xu, Changhua Qu, et al.
International Immunopharmacology (2021) Vol. 98, pp. 107844-107844
Closed Access | Times Cited: 139
Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress
Saikat Dewanjee, Pratik Chakraborty, Hiranmoy Bhattacharya, et al.
Free Radical Biology and Medicine (2022) Vol. 193, pp. 134-157
Closed Access | Times Cited: 127
Structural Brain Changes Associated with Overweight and Obesity
Erick Gómez Apo, Alejandra Mondragón‐Maya, Martina Ferrari-Díaz, et al.
Journal of Obesity (2021) Vol. 2021, pp. 1-18
Open Access | Times Cited: 110
The promise of music therapy for Alzheimer's disease: A review
Anna Maria Matziorinis, Stefan Koelsch
Annals of the New York Academy of Sciences (2022) Vol. 1516, Iss. 1, pp. 11-17
Open Access | Times Cited: 73
Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health
Mónika Fekete, Andrea Ceglédi, Ágnes Szappanos, et al.
GeroScience (2025)
Open Access | Times Cited: 2
Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer’s disease patients from non-demented subjects
Siranjeevi Nagaraj, Katarzyna Laskowska-Kaszub, Konrad J. Dębski, et al.
Oncotarget (2017) Vol. 8, Iss. 10, pp. 16122-16143
Open Access | Times Cited: 137
Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation
Cheng‐Fang Hsieh, Ching‐Kuan Liu, Ching‐Tien Lee, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 125
Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies
Ralph N. Martins, Victor L. Villemagne, Hamid R. Sohrabi, et al.
Journal of Alzheimer s Disease (2018) Vol. 62, Iss. 3, pp. 965-992
Open Access | Times Cited: 119
TRPM2 Channel Aggravates CNS Inflammation and Cognitive Impairment via Activation of Microglia in Chronic Cerebral Hypoperfusion
Jun Miyanohara, Masashi Kakae, Kazuki Nagayasu, et al.
Journal of Neuroscience (2018) Vol. 38, Iss. 14, pp. 3520-3533
Open Access | Times Cited: 118
The Vascular Hypothesis of Alzheimer’s Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging
Jack de la Torre
Journal of Alzheimer s Disease (2018) Vol. 63, Iss. 1, pp. 35-52
Closed Access | Times Cited: 116
Investigation of the neuroprotective effects of crocin via antioxidant activities in HT22 cells and in mice with Alzheimer's disease
Chunyue Wang, Xueying Cai, Wenji Hu, et al.
International Journal of Molecular Medicine (2018)
Open Access | Times Cited: 112
Astragalus membranaceus-Polysaccharides Ameliorates Obesity, Hepatic Steatosis, Neuroinflammation and Cognition Impairment without Affecting Amyloid Deposition in Metabolically Stressed APPswe/PS1dE9 Mice
Yung‐Cheng Huang, Huey-Jen Tsay, Mei‐Kuang Lu, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 12, pp. 2746-2746
Open Access | Times Cited: 99
Polyphenols and neuroprotection: Therapeutic implications for cognitive decline
Giuseppe Caruso, Sebastiano Alfio Torrisi, Maria P. Mogavero, et al.
Pharmacology & Therapeutics (2021) Vol. 232, pp. 108013-108013
Closed Access | Times Cited: 99
Sex differences in the response to oxidative and proteolytic stress
John Tower, Laura C.D. Pomatto, Kelvin J.A. Davies
Redox Biology (2020) Vol. 31, pp. 101488-101488
Open Access | Times Cited: 96
Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future?
Simon Bell, Katy Barnes, Matteo De Marco, et al.
Biomedicines (2021) Vol. 9, Iss. 1, pp. 63-63
Open Access | Times Cited: 95
Alzheimer’s disease (AD) therapeutics – 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality
Kevin Mullane, Michael Williams
Biochemical Pharmacology (2018) Vol. 158, pp. 359-375
Closed Access | Times Cited: 94
Role of Nitric Oxide in Neurodegeneration: Function, Regulation, and Inhibition
Devesh Tewari, Archana N. Sah, Sweta Bawari, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 2, pp. 114-126
Open Access | Times Cited: 91
High-resolution mapping of brain vasculature and its impairment in the hippocampus of Alzheimer's disease mice
Xiaochuan Zhang, Xianzhen Yin, Jingjing Zhang, et al.
National Science Review (2019) Vol. 6, Iss. 6, pp. 1223-1238
Open Access | Times Cited: 88
Page 1 - Next Page

Scroll to top